FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to liquid pharmaceutical compositions of gabapentin. Liquid pharmaceutical composition of gabapentin, characterized by its containing 2–40 wt.% of gabapentin, 0.5–10 wt.% of an excipient, up to 100 wt.% of an inert liquid carrier, while silicon dioxide is used as an excipient, an aprotic liquid carrier is used as an inert liquid carrier. Liquid pharmaceutical composition of gabapentin which differs from the above by its containing a flavoring agent of 0.1–10 wt.%.
EFFECT: above group of inventions makes it possible to obtain a storage-stable liquid pharmaceutical composition of gabapentin with improved taste characteristics.
8 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREGABALIN COMPOSITION | 2004 |
|
RU2352333C2 |
| STABLE LIQUID PHARMACEUTICAL COMPOSITION OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DISUCCINATE COMPLEX, HAVING ANTIHYPOXIC, ANTIOXIDANT AND ADAPTOGENIC ACTION | 2013 |
|
RU2527347C1 |
| LIQUID COMPOSITIONS CONTAINING TASIMELTEON AND METHODS OF THEIR USE | 2020 |
|
RU2806302C1 |
| LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION, HAVING NOOTROPIC ACTIVITY | 2018 |
|
RU2703293C1 |
| LIQUID PHARMACEUTICAL COMPOSITION OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2021 |
|
RU2783660C2 |
| LIQUID DOSAGE FORM OF FENSPIRIDE AND PRODUCTION METHOD THEREOF | 2015 |
|
RU2607965C1 |
| ANTIBACTERIAL COMPOSITION FOR DELIVERY OF GRAMICIDIN C TO THE LOCUS OF LOCAL INFLAMMATION, METHOD FOR PREPARING ANTIBACTERIAL COMPOSITION FOR DELIVERING GRAMICIDIN C TO LOCUS OF LOCAL INFLAMMATION, METHOD FOR DELIVERING GRAMICIDIN C TO LOCUS OF LOCAL INFLAMMATION | 2017 |
|
RU2659418C1 |
| LIQUID DOSAGE FORM FOR TREATING AND PREVENTING INFLUENZA AND ARVI | 2018 |
|
RU2737086C2 |
| LIQUID DOSAGE FORM FOR TREATING AND PREVENTING INFLUENZA AND SARS | 2020 |
|
RU2744854C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING DHMEQ OR ITS ANALOGUES | 2018 |
|
RU2703735C1 |
